This site is intended for Healthcare Professionals.
EUA Fact Sheet Updates
Please be aware that Pfizer-BioNTech COVID-19 Vaccine is now available in three formulations. For additional information on differences across age groups and formulations please see Vaccine Formulations Guide on the home page of this website.
To Azerbaijan the formulation in a multiple dose vial with a purple cap FOR 12 YEARS OF AGE AND OLDER was supplied.
Label Update: Effective 17 May 2022
Second Booster Dose: 12 years of age and older
• A second booster dose of the Pfizer-BioNTech COVID-19 Vaccine (0.3 mL) may be administered to individuals 50 years of age and older at least 4 months after receipt of a first booster dose of any authorised or approved COVID-19 vaccine.
• A second booster dose of the Pfizer-BioNTech COVID-19 Vaccine (0.3 mL) may be administered at least 4 months after receipt of a first booster dose of any authorised or approved COVID-19 vaccine to individuals 12 years of age and older with certain kinds of immunocompromise
Expiry dates extending from 9 months to 12 months for all formulations.
Important Safety Information updated to include new data on myocarditis and pericarditis.
Click below to view:
• EUA Fact Sheet for Vaccination Providers - 12 year of age and older Dilute Before Use, Purple Cap
For healthcare professionals only
zerThe information contained on this site is reserved exclusively for healthcare professionals resident in Azerbaijan.
I confirm that I am a healthcare professional resident in Azerbaijan.
Not a Healthcare Professional in Azerbaijan? This website is not intended for patients or for members of the general public.